Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Factor Therapeutics Ltd (FTT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6399
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor which is being developed to treat venous leg ulcers. FTL offers cell culture reagents to enhance the growth of mammalian cells for cell-based therapies. The company’s VF-001 pursues the development of other product candidates which may be applicability to other wound care applications. It utilizes third parties for development and commercialization of its novel products. FTL is headquartered in Brisbane, Queensland, Australia.

Factor Therapeutics Ltd (FTT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Factor Therapeutics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Factor Therapeutics Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Factor Therapeutics Raises USD3.3 Million in Rights Offering of Shares 10
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 11
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 13
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 14
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 16
Factor Therapeutics Ltd – Key Competitors 17
Factor Therapeutics Ltd – Key Employees 18
Factor Therapeutics Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Other Significant Developments 20
Jul 27, 2018: Factor Therapeutics: Appendix 4c – June 2018 quarter 20
Apr 26, 2018: Factor Therapeutics: Appendix 4C – March 2018 Quarter 21
Oct 30, 2017: Factor Therapeutics: Appendix 4C – September 2017 Quarter 22
Jul 31, 2017: Factor Therapeutics: Appendix 4C – June 2017 Quarter 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Factor Therapeutics Ltd, Medical Equipment, Key Facts, 2017 2
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Factor Therapeutics Ltd, Deals By Market, 2012 to YTD 2018 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Factor Therapeutics Raises USD3.3 Million in Rights Offering of Shares 10
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 11
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 13
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 14
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 16
Factor Therapeutics Ltd, Key Competitors 17
Factor Therapeutics Ltd, Key Employees 18
Factor Therapeutics Ltd, Other Locations 19
Factor Therapeutics Ltd, Subsidiaries 19

List of Figures
Factor Therapeutics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Factor Therapeutics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Factor Therapeutics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mapfre S.A. (MAP):企業の財務・戦略的SWOT分析
    Mapfre S.A. (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fuji Heavy Industries, Ltd.:戦略・SWOT・企業財務分析
    Fuji Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Terumo Corp (4543):製薬・医療:M&Aディール及び事業提携情報
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • Companhia Siderurgica Nacional:企業の戦略・SWOT・財務情報
    Companhia Siderurgica Nacional - Strategy, SWOT and Corporate Finance Report Summary Companhia Siderurgica Nacional - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gordon Food Service:戦略・SWOT・企業財務分析
    Gordon Food Service - Strategy, SWOT and Corporate Finance Report Summary Gordon Food Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Monitise plc:企業のM&A・事業提携・投資動向
    Monitise plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Monitise plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Wacker Chemie AG (WCH):企業の財務・戦略的SWOT分析
    Wacker Chemie AG (WCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Duke Energy Indiana, LLC:発電所・企業SWOT分析
    Duke Energy Indiana, LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BliNK Biomedical SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary BliNK Biomedical SAS (BliNK Biomedical) is a drug development company that discovers and develops antibody-based therapeutics for life threatening diseases such as cancer. The company’s lead pipeline program is a monoclonal antibody that targets novel immune-oncology and immune-checkpoint ta …
  • DXI Energy Inc (DXI):石油・ガス:M&Aディール及び事業提携情報
    Summary DXI Energy Inc (DXI Energy), formerly Dejour Energy Inc is an upstream oil and gas company. The company undertakes the business of oil and gas exploration, distribution and production. It explores for oil and gas properties in regions of Colorado and British Columbia. DXI Energy operates pro …
  • Levi Strauss & Co.:企業の戦略・SWOT・財務情報
    Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report Summary Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KPIT Technologies Ltd (BSOFT):企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • MediciNova Inc (MNOV)-製薬・医療分野:企業M&A・提携分析
    Summary MediciNova Inc (MediciNova) is a biopharmaceutical company, which focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs such as MN-001, for the treatm …
  • Taiwan Cooperative Bank, Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cipla Ltd (CIPLA):企業の財務・戦略的SWOT分析
    Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pennon Group Plc:企業の戦略・SWOT・財務分析
    Pennon Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pennon Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆